Antibodies

SARS-CoV-2 Antibodies from ProSci

To support the efforts of researchers worldwide in understanding and combating SARS-CoV-2, ProSci Inc has developed and manufactured COVID-19 (SARS-CoV-2, 2019-nCoV) antibodies and research reagents against the virus, and virus receptor ACE2. Polyclonal antibodies and monoclonal antibodies are available against

Interleukin-6 release in response to Coronavirus 19

Coronavirus 19 is known to infect the respiratory tract and cause mild or highly acute respiratory syndrome. A consequence of this is the release of pro-inflammatory cytokines, including interleukin (IL)-1β and IL-6 (1). This hyperinflammatory response is thought to be

What’s New at Diaclone?

The Diaclone name has stood for quality and reliability for 34 years. Based in Besançon, France, Diaclone pride themselves on excellence in monoclonal antibody and immunoassay development and manufacture. The expanding range of Diaclone immunology products is specifically designed to

What’s the KD of my Antibody?

Understanding binding affinity is an important part of the drug discovery process, ensuring that therapeutic antibodies that bind their targets selectively and specifically. It also helps to understand the intermolecular interactions driving biological processes, structural biology, and structure-function relationships. KD

Recombinant Monoclonal Antibodies [RecMAbs™] – Produced with No Use of Animals

Antibody phage display is an in vitro technology to generate recombinant monoclonal antibodies (RecMAbs™) without the use of animals.

Antibody Validation

A committee, including Adipogen, made guidelines for antibody validation & detailed context-dependent measures to be followed by antibody suppliers.

Single Domain Antibodies: Tools for the Future?

Single Domain Antibodies (aka Nanobodies, VHH antibodies & camelid antibodies) are at the forefront of research in HIV, cancer, & other cell diseases.

Applications for Single Domain Antibody

The single-domain antibodies (sdAb), lack light chains, yet possess unique characteristics providing researchers a myriad of options not readily available with conventional antibodies. In comparison, the sdAbs boast significantly higher stability and are much smaller in size, only 15kd. As

New Neuronal Markers

Neuromics’ continually add new antibodies to their portfolio to further aid in scientific research. Many of the new additions are part of their frequently used and widely published Neuron-Glial Markers. All Neuromics’ products are tested, characterized and research ready.

Risk-Free™ Immune Checkpoint Antibody Sets

ProSci Inc. offers an extensive range of antibodies and supporting tools to research PD-L2 Read more about their range below, or click a link to jump to a specific section: Multiple antibodies for multiple applications Development of Risk-Free™ Antibody Sets